You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adalimumab

Showing 26 - 50 of 818
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Irritable Bowel Disease Trial in Cairo (Infliximab, Adalimumab)

Recruiting
  • Irritable Bowel Disease
  • Cairo, Egypt
    Tropical Medicine department, Ain Shams University Hospitals.
Mar 12, 2022

Application of N-of-1 Rheumatoid Arthritis

Not yet recruiting
  • Arthritis, Rheumatoid
  • Adalimumab
  • +2 more
  • Boston, Massachusetts
    Tufts Medical Center
Aug 24, 2023

Non-infectious Intermediate Posterior- or Pan-uveitis Trial in China (Adalimumab)

Recruiting
  • Non-infectious Intermediate Posterior- or Pan-uveitis
  • Adalimumab
  • Beijing, Beijing, China
  • +7 more
Dec 6, 2022

Healthy Volunteers Trial in Madrid (PBP1502, EU-licensed Humira, US-licensed Humira)

Recruiting
  • Healthy Volunteers
  • Madrid, Spain
    Unidad de Fase I. U. Autonoma de Madrid (Clinical Trials Unit, U
Sep 26, 2022

Clinical Study of Stage IV Psoriasis in Children With Geleli

Not yet recruiting
  • Plaque Psoriasis
    • (no location specified)
    Mar 26, 2023

    Inflammatory Bowel Disease in Egyptian Patients

    Completed
    • IBD
      • Cairo, Egypt
        Faculty of pharmacy-Helwan University
      Feb 7, 2023

      Uveitis Trial in Guangzhou (Adalimumab plus Methotrexate)

      Recruiting
      • Uveitis
      • Adalimumab plus Methotrexate
      • Guangzhou, Guangdong, China
        Zhongshan Ophthalmic Center, Sun Yat-sen University
      Dec 26, 2021

      Uveitis Trial (Adalimumab plus different doses of oral glucocorticosteroid)

      Not yet recruiting
      • Uveitis
      • Adalimumab plus different doses of oral glucocorticosteroid
      • (no location specified)
      Nov 1, 2021

      Plaque Psoriasis Trial in Beijing (HLX03, adalimumab)

      Completed
      • Plaque Psoriasis
      • Beijing, China
        Peking University People's Hospital
      May 4, 2022

      Rheumatoid Arthritis Trial in Beijing (Geleli)

      Not yet recruiting
      • Rheumatoid Arthritis
      • Beijing, China
        Peking University People's Hospital
      Feb 6, 2022

      Takayasu Arteritis Trial in Beijing (Adalimumab Injection, Tofacitinib 5 MG)

      Recruiting
      • Takayasu Arteritis
      • Adalimumab Injection
      • Tofacitinib 5 MG
      • Beijing, China
      • +3 more
      Feb 26, 2022

      Fate in Fistulizing Crohn's Disease in a Pediatric Population

      Active, not recruiting
      • Crohn Disease
      • (no location specified)
      Feb 25, 2023

      Crohn's Disease Trial in Petach Tikva (Adalimumab)

      Completed
      • Crohn's Disease
      • Adalimumab
      • Petach Tikva, Israel
        Schneider Children's Hospital
      Sep 25, 2021

      Pharmacokinetics, Safety, Efficacy Trial in Dhaka (Advixa (Adalimumab))

      Recruiting
      • Pharmacokinetics
      • +3 more
      • Advixa (Adalimumab)
      • Dhaka, Bangladesh
        ideSHi
      Jul 6, 2022

      Uveitis Trial in Spain (Methotrexate, Adalimumab, Adalimumab+Methotrexate)

      Recruiting
      • Uveitis
      • A Coruña, Spain
      • +13 more
      Mar 15, 2022

      Uveitis, Adalimumab Trial in Guangzhou (reduction or discontinuation of Adalimumab)

      Recruiting
      • Uveitis
      • Adalimumab
      • reduction or discontinuation of Adalimumab
      • Guangzhou, Guangdong, China
        Zhongshan Ophthalmic Center, Sun Yat-sen University
      Dec 9, 2021

      Subcutaneous HUMIRA Injection to Assess Adverse Events and

      Recruiting
      • Crohn's Disease
        • Beijing, Beijing, China
        • +8 more
        Jan 12, 2023

        bIosimilar of aDalimumab, an European evAluation

        Not yet recruiting
        • Rheumatoid Arthritis
        • +4 more
          • (no location specified)
          Jan 4, 2022

          Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.

          Recruiting
          • Rheumatoid Arthritis
          • +2 more
          • Infliximab: Adalimumab; Etanercept;
          • Sulaymaniyah, Kurdistan Region, Iraq
            Hiwa Khidhir Saaed
          May 12, 2022

          Pain, Injection Site Trial in Leiden (Adalimumab ID, Adalimumab SC, Saline ID)

          Completed
          • Pain
          • Injection Site
          • Adalimumab ID
          • +3 more
          • Leiden, Netherlands
            Centre for Human Drug Research
          Aug 2, 2021

          Psoriasis Trial in Saint Petersburg (BCD-057, Humira®)

          Completed
          • Psoriasis
          • BCD-057
          • Humira®
          • Saint Petersburg, Strelna, Russian Federation
            BIOCAD
          Sep 6, 2021

          Benign Prostatic Hyperplasia (BPH) Trial in Glenview (Adalimumab)

          Not yet recruiting
          • Benign Prostatic Hyperplasia (BPH)
          • Adalimumab
          • Glenview, Illinois
            NorthShore University HealthSystem
          Sep 25, 2023

          Golimumab in Juvenile Idiopathic Arthritis-associated Uveitis

          Completed
          • JIA Associated Uveitis
          • (no location specified)
          Sep 1, 2021

          Psoriasis Trial (risankizumab, adalimumab, for risankizumab)

          Completed
          Has Results
          • Psoriasis
          • (no location specified)
          Jul 28, 2021

          Tuberculous Meningitis, HIV I Infection Trial in Rio De Janeiro, Maputo, Lusaka (Adalimumab Injection)

          Not yet recruiting
          • Tuberculous Meningitis
          • HIV I Infection
          • Adalimumab Injection
          • Rio De Janeiro, Brazil
          • +2 more
          Jan 31, 2023